nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0937	0.383	CbGeAlD
Trisalicylate-choline—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0431	0.104	CcSEcCtD
Trisalicylate-choline—Hypothermia—Metformin—polycystic ovary syndrome	0.0431	0.104	CcSEcCtD
Trisalicylate-choline—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0382	0.113	CbGpPWpGaD
Trisalicylate-choline—Upset stomach—Metformin—polycystic ovary syndrome	0.0368	0.0886	CcSEcCtD
Trisalicylate-choline—Heartburn—Metformin—polycystic ovary syndrome	0.0351	0.0843	CcSEcCtD
Trisalicylate-choline—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0239	0.0703	CbGpPWpGaD
Trisalicylate-choline—Lightheadedness—Metformin—polycystic ovary syndrome	0.0216	0.0519	CcSEcCtD
Trisalicylate-choline—Lethargy—Metformin—polycystic ovary syndrome	0.0179	0.043	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.016	0.0385	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0145	0.0349	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0144	0.0424	CbGpPWpGaD
Trisalicylate-choline—Drowsiness—Metformin—polycystic ovary syndrome	0.0135	0.0325	CcSEcCtD
Trisalicylate-choline—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.0127	0.0374	CbGpPWpGaD
Trisalicylate-choline—PTGS2—embryo—polycystic ovary syndrome	0.0127	0.0518	CbGeAlD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0123	0.0362	CbGpPWpGaD
Trisalicylate-choline—Hepatitis—Metformin—polycystic ovary syndrome	0.0121	0.0291	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0114	0.0337	CbGpPWpGaD
Trisalicylate-choline—Flushing—Metformin—polycystic ovary syndrome	0.0112	0.027	CcSEcCtD
Trisalicylate-choline—Erythema—Metformin—polycystic ovary syndrome	0.0106	0.0254	CcSEcCtD
Trisalicylate-choline—PTGS2—adrenal cortex—polycystic ovary syndrome	0.0104	0.0424	CbGeAlD
Trisalicylate-choline—Dysgeusia—Metformin—polycystic ovary syndrome	0.0103	0.0248	CcSEcCtD
Trisalicylate-choline—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.00976	0.0288	CbGpPWpGaD
Trisalicylate-choline—PTGS1—endometrium—polycystic ovary syndrome	0.0097	0.0396	CbGeAlD
Trisalicylate-choline—PTGS2—endometrium—polycystic ovary syndrome	0.00927	0.0379	CbGeAlD
Trisalicylate-choline—PTGS1—uterus—polycystic ovary syndrome	0.00894	0.0365	CbGeAlD
Trisalicylate-choline—PTGS1—pituitary gland—polycystic ovary syndrome	0.00878	0.0359	CbGeAlD
Trisalicylate-choline—PTGS1—adipose tissue—polycystic ovary syndrome	0.00874	0.0357	CbGeAlD
Trisalicylate-choline—Oedema—Metformin—polycystic ovary syndrome	0.00861	0.0207	CcSEcCtD
Trisalicylate-choline—PTGS2—uterus—polycystic ovary syndrome	0.00854	0.0349	CbGeAlD
Trisalicylate-choline—Shock—Metformin—polycystic ovary syndrome	0.00847	0.0204	CcSEcCtD
Trisalicylate-choline—PTGS2—pituitary gland—polycystic ovary syndrome	0.00839	0.0343	CbGeAlD
Trisalicylate-choline—PTGS2—adipose tissue—polycystic ovary syndrome	0.00835	0.0342	CbGeAlD
Trisalicylate-choline—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00832	0.02	CcSEcCtD
Trisalicylate-choline—Anorexia—Metformin—polycystic ovary syndrome	0.00821	0.0197	CcSEcCtD
Trisalicylate-choline—Hypotension—Metformin—polycystic ovary syndrome	0.00805	0.0193	CcSEcCtD
Trisalicylate-choline—PTGS1—adrenal gland—polycystic ovary syndrome	0.00784	0.0321	CbGeAlD
Trisalicylate-choline—Somnolence—Metformin—polycystic ovary syndrome	0.00765	0.0184	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Metformin—polycystic ovary syndrome	0.00758	0.0182	CcSEcCtD
Trisalicylate-choline—PTGS2—adrenal gland—polycystic ovary syndrome	0.00749	0.0306	CbGeAlD
Trisalicylate-choline—Decreased appetite—Metformin—polycystic ovary syndrome	0.00748	0.018	CcSEcCtD
Trisalicylate-choline—Constipation—Metformin—polycystic ovary syndrome	0.00736	0.0177	CcSEcCtD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.00731	0.0215	CbGpPWpGaD
Trisalicylate-choline—PTGS1—female gonad—polycystic ovary syndrome	0.00731	0.0299	CbGeAlD
Trisalicylate-choline—PTGS1—vagina—polycystic ovary syndrome	0.00727	0.0297	CbGeAlD
Trisalicylate-choline—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0071	0.0171	CcSEcCtD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00708	0.0208	CbGpPWpGaD
Trisalicylate-choline—PTGS2—female gonad—polycystic ovary syndrome	0.00699	0.0286	CbGeAlD
Trisalicylate-choline—PTGS2—vagina—polycystic ovary syndrome	0.00694	0.0284	CbGeAlD
Trisalicylate-choline—Urticaria—Metformin—polycystic ovary syndrome	0.00684	0.0164	CcSEcCtD
Trisalicylate-choline—PTGS1—endocrine gland—polycystic ovary syndrome	0.0068	0.0278	CbGeAlD
Trisalicylate-choline—PTGS2—endocrine gland—polycystic ovary syndrome	0.0065	0.0266	CbGeAlD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00622	0.0183	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Metformin—polycystic ovary syndrome	0.00609	0.0146	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Metformin—polycystic ovary syndrome	0.00589	0.0142	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.0057	0.0168	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Metformin—polycystic ovary syndrome	0.00569	0.0137	CcSEcCtD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00562	0.0165	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Metformin—polycystic ovary syndrome	0.00547	0.0132	CcSEcCtD
Trisalicylate-choline—Rash—Metformin—polycystic ovary syndrome	0.00543	0.0131	CcSEcCtD
Trisalicylate-choline—Dermatitis—Metformin—polycystic ovary syndrome	0.00542	0.013	CcSEcCtD
Trisalicylate-choline—Headache—Metformin—polycystic ovary syndrome	0.00539	0.013	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00536	0.0158	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00528	0.0156	CbGpPWpGaD
Trisalicylate-choline—Nausea—Metformin—polycystic ovary syndrome	0.00511	0.0123	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00494	0.0145	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00444	0.0131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.00436	0.0129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00426	0.0125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00419	0.0124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.00405	0.0119	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00379	0.0112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00353	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0033	0.00971	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00306	0.00902	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00301	0.00885	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00297	0.00876	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00279	0.00821	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.00258	0.0076	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00256	0.00754	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00243	0.00715	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00242	0.00714	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00237	0.00697	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00236	0.00695	CbGpPWpGaD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00225	0.00662	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00221	0.00652	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00204	0.00602	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00203	0.00599	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00198	0.00582	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00196	0.00577	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00195	0.00576	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00188	0.00552	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00186	0.00547	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00175	0.00516	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.0017	0.005	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00167	0.00493	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00165	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00163	0.00479	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00157	0.00464	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00156	0.00458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00154	0.00454	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00149	0.00438	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00148	0.00437	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00148	0.00437	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00146	0.00429	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00141	0.00417	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00133	0.0039	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00132	0.00388	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00131	0.00387	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00129	0.00379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00125	0.00368	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00124	0.00366	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00121	0.00356	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00118	0.00347	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00118	0.00347	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00118	0.00347	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00118	0.00346	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00112	0.00331	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00111	0.00327	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00104	0.00308	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00104	0.00306	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000986	0.0029	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000967	0.00285	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000959	0.00283	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000955	0.00281	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000935	0.00275	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000915	0.0027	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000915	0.00269	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000913	0.00269	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000892	0.00263	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000871	0.00257	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000866	0.00255	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000851	0.00251	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000835	0.00246	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000835	0.00246	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000825	0.00243	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000779	0.00229	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000776	0.00229	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000774	0.00228	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000759	0.00224	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000758	0.00223	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000725	0.00213	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000708	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000691	0.00204	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000676	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000672	0.00198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000663	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000663	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00066	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.00066	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000655	0.00193	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000635	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000625	0.00184	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000616	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000602	0.00177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000575	0.00169	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000562	0.00166	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000553	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000543	0.0016	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000534	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000524	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000524	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000524	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000504	0.00148	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.0005	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000496	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000495	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000474	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000456	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000446	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000446	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000439	0.00129	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000425	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000423	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00042	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000416	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000399	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000397	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000393	0.00116	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000388	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000379	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000367	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000361	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000355	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000354	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000348	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000338	0.000995	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000338	0.000995	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000334	0.000983	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000327	0.000964	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000323	0.000951	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.00032	0.000944	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000316	0.000932	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000315	0.000929	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000308	0.000907	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000303	0.000893	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000301	0.000888	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000301	0.000887	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000299	0.000882	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000297	0.000875	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000295	0.000869	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000292	0.000859	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000287	0.000846	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000283	0.000833	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000278	0.00082	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000268	0.00079	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000268	0.000789	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000264	0.000777	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.00026	0.000765	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.00025	0.000738	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000241	0.000709	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000241	0.000709	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000239	0.000705	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000238	0.0007	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000236	0.000695	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000234	0.00069	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000226	0.000665	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000224	0.000661	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000222	0.000654	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000221	0.000651	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.00022	0.000649	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000212	0.000624	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000197	0.000579	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000191	0.000563	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000187	0.000552	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000186	0.000548	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000178	0.000523	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000178	0.000523	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000175	0.000515	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000174	0.000513	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000165	0.000487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000157	0.000462	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000156	0.00046	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000149	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000149	0.000438	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000141	0.000415	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000134	0.000395	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000132	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000132	0.000388	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000131	0.000387	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.00013	0.000384	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—polycystic ovary syndrome	0.000125	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000121	0.000355	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000115	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	0.000107	0.000314	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—polycystic ovary syndrome	0.000105	0.000309	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—polycystic ovary syndrome	0.000104	0.000308	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—polycystic ovary syndrome	5.45e-05	0.000161	CbGpPWpGaD
